Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly.

NCT02342496 is registered in ClinicalTrials.gov with Probi AB as lead sponsor.

NCT NCT02342496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02342496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly.
Lead sponsor
Probi AB
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2015
Completion date
December 4, 2015
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

increased intestinal permeability, low-grade inflammation